Inito has raised $29 million in new funding to invest in and develop AI-engineered antibodies that will help it offer new types of tests and improve the accuracy of existing ones.
© 2020-23 Digest Wire. All rights belong to their respective owners.
Wednesday, December 10, 2025
Fertility startup Inito wants to use AI-designed antibodies to expand at-home health tests
ADVERTISEMENT
Trending
Trouble in paradise as Noosa tightens on England’s Ashes hopes
Downtime in luxury beach resort may yet revive England's Ashes hopes, but the optics could be a...
DigestWire is an automated news feed that utilizes AI technology to gather information from sources with varying perspectives. This allows users to gain a comprehensive understanding of different arguments and make informed decisions. DigestWire is dedicated to serving the public interest and upholding democratic values.
Privacy Policy Terms and Conditions